INTOX Pvt. Ltd. operates as a premier Indian toxicological Contract Research Organisation (CRO), OECD GLP Certified since 2007 by The Netherlands and the Indian GLP Monitoring Authorities. The company specializes in various areas including mammalian toxicology, bioanalytical studies, mutagenicity, environmental toxicity, analytical chemistry, and physical-chemical studies. Established in 1995, INTOX is located on the outskirts of Pune, India, with easy accessibility from Mumbai and connectivity to all major Indian cities through the nearby airport. Notably, in December 2021, INTOX was acquired by Aragen Life Sciences, leading to the attainment of a fully integrated drug discovery CRO/CDMO status. This acquisition has facilitated the packaging of GLP Certified Product Safety Assessment Services with end-to-end drug discovery and manufacturing through Aragen (www.aragen.com), marking a significant milestone in the company's journey.
There is no investment information
No recent news or press coverage available for INTOX Pvt. Ltd..